FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 48 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,613,120 | +83.0% | 272,200 | +59.2% | 0.91% | +215.6% |
| Q2 2020 | $1,428,000 | +1730.8% | 171,000 | +1325.0% | 0.29% | +1820.0% |
| Q4 2019 | $78,000 | -93.4% | 12,000 | -95.9% | 0.02% | -95.8% |
| Q2 2019 | $1,180,000 | -61.4% | 295,000 | -53.2% | 0.36% | -57.4% |
| Q1 2019 | $3,056,000 | -46.8% | 630,000 | -30.0% | 0.85% | -60.5% |
| Q4 2018 | $5,742,000 | -28.2% | 900,000 | -7.7% | 2.14% | +5.4% |
| Q3 2018 | $7,995,000 | -19.0% | 975,000 | +3.2% | 2.03% | -20.3% |
| Q2 2018 | $9,865,000 | -6.6% | 945,000 | +8.2% | 2.55% | -15.4% |
| Q1 2018 | $10,559,000 | +24.4% | 873,000 | +3.1% | 3.02% | +11.1% |
| Q4 2017 | $8,486,000 | – | 846,900 | – | 2.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |